SeqLL Inc.

NASDAQ: SQL · Real-Time Price · USD
6.60
-0.16 (-2.37%)
At close: Jan 16, 2025, 10:00 PM

Company Description

SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide.

The company designs, develops, and manufactures genetic analysis technologies.

It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing.

The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc.

It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations.

The company was founded in 2013 and is based in Billerica, Massachusetts.

SeqLL Inc.
SeqLL Inc. logo
Country United States
IPO Date Aug 27, 2021
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 7
CEO Daniel Robert Jones

Contact Details

Address:
3 Federal Street
Billerica, Massachusetts
United States
Website https://seqll.com

Stock Details

Ticker Symbol SQL
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001605888
CUSIP Number 81734C106
ISIN Number US81734C3043
Employer ID 46-5319744
SIC Code 3826

Key Executives

Name Position
Daniel Robert Jones Co-Founder, President, Chief Executive Officer & Chairman
Frances P. Scally Chief Financial Officer & Secretary
John W. Kennedy Chief Financial Officer & Sec.
Brian Paras Chief Business Officer
Erik Volke Director of Operations

Latest SEC Filings

Date Type Title
Jun 25, 2025 4/A [Amend] Filing
Jun 25, 2025 4/A [Amend] Filing
Jun 25, 2025 4/A [Amend] Filing
Jun 23, 2025 S-3 Filing
May 30, 2025 DEFA14A Filing
May 15, 2025 SCHEDULE 13D Filing
May 14, 2025 10-Q Quarterly Report
May 13, 2025 DEF 14A Filing
May 05, 2025 8-K Current Report
Mar 28, 2025 10-K Annual Report